NSC |
Compound |
Enrichment |
Correlation |
NSC 748533 |
1-[2-(3-Chlorophenyl)-2-oxoethyl]-2-acetylbenzimidazole |
0.038506707102734 |
0.45194561 |
NSC 756169 |
GSK317314A |
0.038506707102734 |
-0.13114185 |
NSC 760980 |
Null |
0.038506707102734 |
-0.038263045 |
NSC 761834 |
(Z)-5-chloro-3-((1-(3,5-dimethoxyphenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)indolin-2-one |
0.038506707102734 |
-0.30320211 |
NSC 117915 |
1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] |
0.0385067071027343 |
0.16564859 |
NSC 123461 |
Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) |
0.0385067071027343 |
-0.061876556 |
NSC 150311 |
2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- |
0.0385067071027343 |
0.14470689 |
NSC 150862 |
BLEOMYCIN FRACTION BLM-HPE |
0.0385067071027343 |
0.35215253 |
NSC 159631 |
Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. |
0.0385067071027343 |
0.19681714 |
NSC 278631 |
2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- |
0.0385067071027343 |
0.33034007 |